Currently, the classification of breast cancer is based mainly on the expression of the estrogen receptor (ER), progesterone receptor (PgR), and the overexpression or amplification of human epidermal growth factor receptor 2 (HER2/c-ErbB2). Here, PGR is linked to breast cancer.